Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials
Authors
Keywords
-
Journal
Orphanet Journal of Rare Diseases
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-17
DOI
10.1186/s13023-021-01694-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of modified-release fampridine on upper limb impairment in patients with Multiple Sclerosis
- (2020) Simpson Marion et al. Multiple Sclerosis and Related Disorders
- Effect of dalfampridine on information processing speed impairment in multiple sclerosis
- (2019) Laura De Giglio et al. NEUROLOGY
- Study on Dalfampridine in the treatment of Multiple Sclerosis Mobility Disability: A meta-analysis
- (2019) Jianzhen Shi et al. PLoS One
- Effects of Fampridine in People with Multiple Sclerosis: A Systematic Review and Meta-analysis
- (2019) Maxime Valet et al. CNS DRUGS
- ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) X. Montalban et al. EUROPEAN JOURNAL OF NEUROLOGY
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Cognition in multiple sclerosis
- (2018) James F. Sumowski et al. NEUROLOGY
- Assessment of Clinically Meaningful Improvements in Self-Reported Walking Ability in Participants with Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III ENHANCE Trial of Prolonged-Release Fampridine
- (2018) Jeremy Hobart et al. CNS DRUGS
- Multiple sclerosis - a review
- (2018) R. Dobson et al. EUROPEAN JOURNAL OF NEUROLOGY
- Effects of 4-aminopyridine on attention and executive functions of patients with multiple sclerosis: Randomized, double-blind, placebo-controlled clinical trial. Preliminary report.
- (2018) C. Arreola-Mora et al. Multiple Sclerosis and Related Disorders
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- Reliability, precision, and clinically important change of the Nine-Hole Peg Test in individuals with multiple sclerosis
- (2017) Mario Hervault et al. INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS
- (2017) Sarah A. Morrow et al. Multiple Sclerosis and Related Disorders
- Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study
- (2016) Laure Peyro Saint Paul et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Pediatric multiple sclerosis
- (2016) Maria Pia Amato et al. NEUROLOGY
- Effect of slow release-Fampridine on muscle strength, rate of force development, functional capacity and cognitive function in an enriched population of MS patients. A randomized, double blind, placebo controlled study
- (2016) H.B. Jensen et al. Multiple Sclerosis and Related Disorders
- Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients
- (2015) Katja Pavsic et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life
- (2015) Etienne Allart et al. JOURNAL OF NEUROLOGY
- Home-based training to improve manual dexterity in patients with multiple sclerosis: A randomized controlled trial
- (2015) Christian P Kamm et al. Multiple Sclerosis Journal
- Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial
- (2015) Raymond Hupperts et al. Multiple Sclerosis Journal
- Home-based training to improve manual dexterity in patients with multiple sclerosis: A randomized controlled trial
- (2015) Christian P Kamm et al. Multiple Sclerosis Journal
- Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial
- (2015) Raymond Hupperts et al. Multiple Sclerosis Journal
- Hand dexterity and direct disease related cost in multiple sclerosis
- (2014) Marcus W. Koch et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS
- (2013) J. Hobart et al. NEUROLOGY
- Modeling of Cognitive Impairment by Disease Duration in Multiple Sclerosis: A Cross-Sectional Study
- (2013) Anat Achiron et al. PLoS One
- 4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review
- (2013) Henrik Boye Jensen et al. Therapeutic Advances in Neurological Disorders
- Dalfampridine: A Medication to Improve Walking in Patients with Multiple Sclerosis
- (2012) Theodore E Pikoulas et al. ANNALS OF PHARMACOTHERAPY
- Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living
- (2012) Christian P. Kamm et al. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION
- Cognitive Impairment Occurs in Children and Adolescents With Multiple Sclerosis
- (2012) Laura Julian et al. JOURNAL OF CHILD NEUROLOGY
- Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study
- (2012) Sarah A. Morrow et al. JOURNAL OF NEUROLOGY
- Assessing walking disability in multiple sclerosis
- (2012) Bernd C. Kieseier et al. Multiple Sclerosis Journal
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- L-amphetamine improves memory in MS patients with objective memory impairment
- (2011) James F Sumowski et al. Multiple Sclerosis Journal
- The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue
- (2011) S Huolman et al. Multiple Sclerosis Journal
- A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
- (2010) Andrew D. Goodman et al. ANNALS OF NEUROLOGY
- The effects of l-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial
- (2009) Sarah A. Morrow et al. JOURNAL OF NEUROLOGY
- Cognitive Dysfunction in Multiple Sclerosis: Methods and Prevalence from the GEDMA Study
- (2008) J. Olazarán et al. EUROPEAN NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started